BI Asset Management Fondsmaeglerselskab A S Invests $1.17 Million in Teleflex Incorporated (NYSE:TFX)

BI Asset Management Fondsmaeglerselskab A S acquired a new stake in shares of Teleflex Incorporated (NYSE:TFX - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 6,553 shares of the medical technology company's stock, valued at approximately $1,166,000.

Other hedge funds also recently bought and sold shares of the company. Headlands Technologies LLC purchased a new stake in shares of Teleflex in the fourth quarter valued at approximately $29,000. Avior Wealth Management LLC raised its position in Teleflex by 81.2% in the fourth quarter. Avior Wealth Management LLC now owns 279 shares of the medical technology company's stock valued at $50,000 after purchasing an additional 125 shares during the period. IFP Advisors Inc lifted its stake in Teleflex by 238.5% during the fourth quarter. IFP Advisors Inc now owns 308 shares of the medical technology company's stock worth $55,000 after purchasing an additional 217 shares in the last quarter. Exchange Traded Concepts LLC grew its stake in shares of Teleflex by 38.2% in the fourth quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock valued at $61,000 after buying an additional 94 shares in the last quarter. Finally, R Squared Ltd purchased a new stake in shares of Teleflex in the 4th quarter valued at $64,000. Institutional investors and hedge funds own 95.62% of the company's stock.

Teleflex Trading Up 1.7 %

TFX opened at $131.33 on Wednesday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. Teleflex Incorporated has a one year low of $124.66 and a one year high of $249.91. The company has a market cap of $6.09 billion, a P/E ratio of 26.11, a PEG ratio of 1.73 and a beta of 1.19. The business's 50-day simple moving average is $142.18 and its 200-day simple moving average is $175.99.

Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, topping analysts' consensus estimates of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The company had revenue of $795.40 million for the quarter, compared to analysts' expectations of $813.24 million. As a group, equities research analysts expect that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were paid a $0.34 dividend. The ex-dividend date was Friday, March 7th. This represents a $1.36 annualized dividend and a yield of 1.04%. Teleflex's dividend payout ratio is presently 95.77%.

Wall Street Analyst Weigh In

TFX has been the subject of a number of research analyst reports. Mizuho set a $155.00 target price on Teleflex in a report on Wednesday, April 16th. Piper Sandler restated a "neutral" rating and issued a $140.00 price objective (down previously from $255.00) on shares of Teleflex in a report on Friday, February 28th. Raymond James downgraded shares of Teleflex from an "outperform" rating to a "market perform" rating in a research note on Friday, February 28th. Wells Fargo & Company decreased their price target on shares of Teleflex from $214.00 to $146.00 and set an "equal weight" rating for the company in a research report on Friday, February 28th. Finally, Royal Bank of Canada cut Teleflex from an "outperform" rating to a "sector perform" rating and reduced their price objective for the company from $220.00 to $155.00 in a research note on Friday, February 28th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat.com, Teleflex currently has a consensus rating of "Hold" and an average price target of $169.63.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.